Trial site
South Texas Accelerated Research Therapeutics (START)
- 11running trials
- 4closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Gastric and oesophageal cancer5 trials
- Ovarian cancer5 trials
- Pancreatic cancer5 trials
- Colorectal cancer4 trials
- Bladder cancer3 trials
- Endometrial cancer3 trials
- Head and neck cancer3 trials
- Metastatic breast cancer3 trials
- Prostate cancer3 trials
- Cervical cancer2 trials
- Diffuse large B-cell lymphoma2 trials
- and 7 more
- Phase
- Phase 111 trials
- Phase 1/23 trials
- Phase 21 trial
- Status
- Active, not recruiting8 trials
- Completed4 trials
- Recruiting3 trials
- Lead sponsor
- Eli Lilly and Company8 trials
- Aadi Bioscience, Inc.1 trial
- Celgene1 trial
- Debiopharm International SA1 trial
- Hoffmann-La Roche1 trial
- and 3 more
Running trials
Recruiting
Active, not recruiting
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Active, not recruiting
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Recruiting
Active, not recruiting
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
Recruiting
Active, not recruiting
Active, not recruiting
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Active, not recruiting
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Active, not recruiting
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
Active, not recruiting
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Glioblastoma1 recruiting
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026